34 articles
A new review maps approved vs. gray-market peptides in sports medicine, flagging scarce human safety data behind widely marketed compounds.
Elysium Health moves beyond supplements into integrated longevity medicine, bundling prescriptions, peptides, and clinical monitoring for 10,000 members.
Dr. Valter Longo challenges the peptide and GLP-1 boom, arguing the full body of evidence points toward fasting, plant protein, and lower IGF-1.
Review finds popular peptide therapies like BPC-157 and TB-500 need more rigorous human trials before clinical use.
Recent longevity podcasts explore AI-powered supplement stacks, regenerative medicine breakthroughs, and critical takes on peptide culture.
Fitness expert argues ancestral mismatch principles and simple daily practices outperform costly longevity interventions.
New review reveals how engineered peptides could revolutionize Alzheimer's therapy by targeting multiple disease pathways simultaneously.
The Forever Healthy Foundation adds a transparent, AI-assisted peptide evidence library to help cut through hype and find real clinical signal.
Bryan Johnson offers guidance on peptides — what they are, how they work, and what health-optimizers should consider before using them.
A board-certified physician breaks down BPC-157, epithalon, GLP-1s, and growth hormone peptides — separating real science from hype.
Dr. Abud Bakri covers BPC-157, epithalon, GHK-Cu, GLP-1s, and growth hormone peptides — separating real evidence from hype.
A comprehensive review reveals BPC-157 lacks validated formulations, human PK data, and a coherent drug development path despite 30+ years of preclinical research.
